Peer-reviewedCC BY-NCJournal of Clinical and Translational Hepatology
Omics-based Decoding of Metabolic Dysfunction-associated Fatty Liver Disease: From Pathogenesis to Clinical Translation
- 1Center for Fatty Liver, Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
- 2Institute of Metabolism and Regenerative Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Related
- Metabolic dysfunction-associated steatotic liver disease: Pathogenesis, complications and pharmacological treatment
- Omics-derived signatures in metabolic dysfunction-associated steatotic liver disease: from molecular characterization to clinical translation.
- Multi-omics advances in sepsis-associated encephalopathy: from pathogenesis to clinical translation
- Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis
- Functional and Metabolic Correlates of Age- and Sex-Normalized Handgrip Strength in Children with Metabolic Dysfunction-Associated Steatotic Liver Disease
BibTeX
@article{zhai2026omicsbased,
title = {{Omics-based Decoding of Metabolic Dysfunction-associated Fatty Liver Disease: From Pathogenesis to Clinical Translation}},
author = {Jinyang Zhai and Yan Lu and Jian-Gao Fan},
journal = {Journal of Clinical and Translational Hepatology},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13655730},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Omics-based Decoding of Metabolic Dysfunction-associated Fatty Liver Disease: From Pathogenesis to Clinical Translation
AU - Jinyang Zhai
AU - Yan Lu
AU - Jian-Gao Fan
PY - 2026
DA - 2026/09/10
JO - Journal of Clinical and Translational Hepatology
UR - https://europepmc.org/article/PMC/PMC13655730
SN - 2225-0719
ER -